Dr. Reinhold Penner, Cannabinoids as Modulators of Calcium and Inflammation

June 2023

Dr. Reinhold Penner is the Director of Research at The Center for Biomedical Research at The Queen’s Medical Center in Honolulu, Hawaii. He obtained his PhD from the University of Giessen, Germany, in 1986 and spent his Postdoc time until 1990 in the lab of Nobel Laureate Dr. Erwin Neher at the Max-Planck-Institute for Biophysical Chemistry in Göttingen, Germany. He then became a group leader in Dr. Neher’s department where he worked for 8 years before relocating to Honolulu in 1997. Here he established the Center for Biomedical Research at The Queen’s Medical Center, where he currently serves as the Director of Research. 

He is internationally recognized for his seminal work on ion channels in cell biology with extensive research experience in the areas of immunology, neuroscience, and cardiovascular research, employing methodologies of biophysics, molecular biology, genetics, biochemistry, pharmacology and toxicology. His work has contributed to the understanding of store-operated calcium entry and led to the discovery the Calcium Release-Activated Calcium (CRAC) channels. His laboratory also contributed to the discovery and characterization of several TRP channels, including TRPM2, TRPM4, TRPM5, and TRPM7. His group is now involved in drug discovery efforts for a range of ion channels involved in inflammation, autoimmune diseases, pain, diabetes, and cancer.

More details can be found here.

Previous Webinars

Igor Grant, M.D. and Thomas Marcotte, Ph.D.

Thursday, February 12th at 1:00 PM MST

The UC San Diego Center for Medicinal Cannabis Research: Some Findings

Igor Grant, MD is Distinguished Professor, and Director of the Center for Medicinal Cannabis Research (CMCR) at the University of California San Diego (UCSD). Established in 2000, the CMCR has been at the forefront of advancing science and policy […]

Read More »

Almut Winterstein, PhD.

Jan 8, 2026 01:00 PM Mountain Time

Clinical research priorities gleaned real-world use patterns: the MEdical Marijuana Outcomes Research repositorY (MEMORY)

Almut Winterstein is Distinguished Professor and the Dr. Robert and Barbara Crisafi Chair for Medication Safety in the Department of Pharmaceutical Outcomes and Policy and in the Department of Epidemiology, and the founding Director of the […]

Read More »

Carolyn Baglole, PhD,

December, 11, 2025 1:00 PM MST

Multi-omics dissection of the molecular and pharmacological effects of inhaled cannabis

Professor Carolyn Baglole earned her Bachelor of Science and Master of Science degrees from the University of Prince Edward Island, followed by a PhD in Physiology and Pharmacology from the University of Calgary. Dr. Baglole then completed postdoctoral training at […]

Read More »

Margaret Haney, PhD

Nov 13, 2025 01:00 PM MST

Cannabis Misuse and Therapeutic Potential: Placebo-controlled Laboratory Studies

Dr. Margaret (Meg) Haney is a Professor of Neurobiology (in Psychiatry) at the Columbia University Irving Medical Center. As the Director of the Cannabis Research Laboratory and of the Substance Use Research Center in the Division of Substance Use Disorders, Dr. Haney is […]

Read More »

Inga Zasada, Ph.D.

Wednesday, February 18 at 11:00 AM MST

Dr. Inga Zasada brings over 25 years of expertise in nematology, specializing in the biology and management of plant-parasitic nematodes affecting high-value crops such as hemp. With deep knowledge spanning both chemical and nonchemical control strategies, she provides comprehensive solutions for complex nematode challenges. As owner of NemaSolutions LLC, […]

Read More »

Dan Ovadya, CEO

New Methods for Induction of Male Flowers and Scalable Feminized Seed Production in Cannabis Sativa

Dan Ovadya is the Co-founder and CEO of FloraGen LLC, an AgTech company based in Davis, California. Dan has
over 30 years of experience in crop optimization, precision horticulture and seed production systems in controlled
environments. His career in Ag-Biotech centered on developing […]

Read More »